Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies
What is this summary about? Generalized myasthenia gravis (often shortened to gMG) is a rare health condition that causes muscular weakness. This summary gives an overview of three published articles that report the results of research studies of a medicine called ravulizumab, a treatment approv...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Becaris Publishing Limited
2024-10-01
|
| Series: | Journal of Comparative Effectiveness Research |
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850198650626506752 |
|---|---|
| author | Florencia Aguirre Renata Andrade |
| author_facet | Florencia Aguirre Renata Andrade |
| author_sort | Florencia Aguirre |
| collection | DOAJ |
| description | What is this summary about?
Generalized myasthenia gravis (often shortened to gMG) is a rare health
condition that causes muscular weakness. This summary gives an
overview of three published articles that report the results of research
studies of a medicine called ravulizumab, a treatment approved for
adults with gMG. These studies are:
• The CHAMPION MG study.
• The CHAMPION MG extension study.
• A study of how the body processes and responds to ravulizumab
(known as pharmacokinetics and pharmacodynamics).
These studies looked at how effective and safe ravulizumab is for
people with gMG. |
| format | Article |
| id | doaj-art-67bb5efd245f4d099f051f4d0371a063 |
| institution | OA Journals |
| issn | 2042-6313 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | Becaris Publishing Limited |
| record_format | Article |
| series | Journal of Comparative Effectiveness Research |
| spelling | doaj-art-67bb5efd245f4d099f051f4d0371a0632025-08-20T02:12:49ZengBecaris Publishing LimitedJournal of Comparative Effectiveness Research2042-63132024-10-01131110.57264/cer-2024-0109Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studiesFlorencia Aguirre0Renata Andrade1Neurophysiology and Neuromuscular Diseases Section, Hospital Gral de agudos JM Ramos Mejía, Buenos Aires, ArgentinaDivision of Rare Diseases, Real Hospital Português, Recife, BrazilWhat is this summary about? Generalized myasthenia gravis (often shortened to gMG) is a rare health condition that causes muscular weakness. This summary gives an overview of three published articles that report the results of research studies of a medicine called ravulizumab, a treatment approved for adults with gMG. These studies are: • The CHAMPION MG study. • The CHAMPION MG extension study. • A study of how the body processes and responds to ravulizumab (known as pharmacokinetics and pharmacodynamics). These studies looked at how effective and safe ravulizumab is for people with gMG.generalized myasthenia gravisgmgmuscular weaknessplain language summaryravulizumab |
| spellingShingle | Florencia Aguirre Renata Andrade Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies Journal of Comparative Effectiveness Research generalized myasthenia gravis gmg muscular weakness plain language summary ravulizumab |
| title | Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies |
| title_full | Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies |
| title_fullStr | Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies |
| title_full_unstemmed | Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies |
| title_short | Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies |
| title_sort | ravulizumab for adults with generalized myasthenia gravis a plain language summary of three studies |
| topic | generalized myasthenia gravis gmg muscular weakness plain language summary ravulizumab |
| work_keys_str_mv | AT florenciaaguirre ravulizumabforadultswithgeneralizedmyastheniagravisaplainlanguagesummaryofthreestudies AT renataandrade ravulizumabforadultswithgeneralizedmyastheniagravisaplainlanguagesummaryofthreestudies |